Back
4D Molecular Therapeutics Quote, Financials, Valuation and Earnings
Sell
35
FDMT
4D Molecular Therapeutics
Last Price:
25.31
Seasonality Move:
0.41%
7 Day Trial
ALL ACCESS PASS
$
7
4D Molecular Therapeutics Price Quote
$25.31
-0.03 (-1.29%)
(Updated: May 18, 2024 at 5:42 AM ET)
4D Molecular Therapeutics Key Stats
Sell
35
4D Molecular Therapeutics (FDMT)
is a Sell
Day range:
$24.36 - $25.72
52-week range:
$9.44 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
53.50
P/B ratio:
2.18%
Volume:
438.4K
Avg. volume:
459.2K
1-year change:
39.38%
Market cap:
$1.3B
Revenue:
$20.7M
EPS:
$-2.44
How Much Does 4D Molecular Therapeutics Make?
-
How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M -
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M
Is 4D Molecular Therapeutics Growing As A Company?
-
What Is 4D Molecular Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.91% -
What Is 4D Molecular Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
4D Molecular Therapeutics Stock Price Performance
-
Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went up by 0.16% last month -
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price rose by 39.38% over the past 1 year
What Is 4D Molecular Therapeutics 52-Week High & Low?
-
What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks -
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $9.44 over the past 52 weeks
4D Molecular Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy 4D Molecular Therapeutics?
-
How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $525.9M -
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 11.74
Is 4D Molecular Therapeutics Cash Flow Positive?
-
What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$77M -
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $464.7M -
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$190.7M
4D Molecular Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FDMT return on invested capital is -29.34% -
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.12% -
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -29.34%
4D Molecular Therapeutics Earnings Date & Stock Price
-
What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 25.34 -
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT -
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on August 9, 2024 -
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is May 20, 2024 -
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
4D Molecular Therapeutics Competitors
-
Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
4D Molecular Therapeutics Dividend Yield
Data Unavailable
4D Molecular Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 12.8% |
Revenue: | -90.6% | -97.38% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 52.30 |
Upside from Last Price: | 106.39% |